Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: MJNA

MJNA Numbers Don’t Lie This is a Company on the Rise

Medical Marijuana, Inc. has earned its title as a leader in the medical marijuana industry. It’s pioneering the way for more acceptance of medicinal marijuana as well as deriving revolutionary products. Today, the company is yet again proving itself and standing stronger than ever with record sales for a month.

Who is Medical Marijuana, Inc.?

Medical Marijuana, Inc, is a premier hemp and cannabis industry leader. With innovative ideas from experts in the field, the company is continuing to develop unique products that benefit overall health and wellness. The company focuses on creating awareness about the cannabis industry. The company develops environmentally-friendly and sustainable products. Additionally, Medical Marijuana, Inc. increases shareholder value with each and every product they develop.

Medical Marijuana, Inc. touts about being a company of firsts. It’s the first publicly traded cannabis company ever in the United States. Moreover, it’s the first direct sales and network …

Continue Reading

Posted in Articles| Tagged , , , , |

Medical Marijuana, Inc. Announces Robert “Bo” Brannin as Senior Director of Operations for Subsidiary Kannaway®

SAN DIEGO, Oct.18, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary Kannaway®  LLC is welcoming Robert “Bo” Brannin as its new Senior Director of Operations.

In this position, Brannin will be responsible for managing every aspect of the company’s supply chain operations from purchasing to inventory, production and shipping. He will bring his twenty years of experience in the operations and logistics field to assist the team in building a strong foundation as the company now prepares to establish international operations. 

“We are excited to bring Bo onto the executive team as Senior Director of Operations and we are more than confident that he has the experience and skills required to effectively serve all of Kannaway’s loyal customers and Brand Ambassadors.” said Kannaway CEO, Blake Schroeder. 

“It is my firm belief that it is critical to …

Continue Reading

Posted in Client News| Tagged |

MJNA Offers the Ideal Option for Athletes in Massive Recovery Market

Medical Marijuana, Inc. is a company that carved out a significant section of a highly competitive market in 2016 and 2017, and it stands to gain even more traction on the international market in the years to come. A major international move for the company promises to expand its market share and yield new growth opportunities in a global sphere.

Medical Marijuana Markets in the United States

It is estimated that the legal marijuana industry has a value of $7.1 billion in the United States alone. This figure is expected to see continued growth throughout the remainder of 2017 and well into 2018 as the American public and medical community become more aware of the benefits of CBD oil products. While this figure includes both legal recreational and medicinal use in the United States, medical marijuana products show unprecedented potential for market growth due to their versatile treatment indications.



Continue Reading
Posted in Articles| Tagged , , , |

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces Results from Clinical Study Including Real Scientific Hemp Oil-X™ (RSHO-X™) on Patients with Tuberous Sclerosis Complex (TSC)

Using CBD to Treat TSC Infographic

Mexican Neurologist Reports 60% of Study Participants Who Used CBD Products Saw Clinically Significant Reduction of Seizures

SAN DIEGO, Oct. 12, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the U.S., today announced that a recent clinical study conducted by renowned Mexico neurologist, Dr. Carlos G. Aguirre-Velazquez, successfully utilized its flagship THC-free product Real Scientific Hemp Oil-X™ (RSHO-X™).

The study targeted the reduction in frequency, intensity and duration of convulsive crises in people with tuberous sclerosis complex (TSC) and saw promising results from cannabidiol (CBD) as a treatment for patients with TSC. Other factors observed in the study were quality of life, dependence on heavy prescription drugs and long-term sustainability of treatment with CBD.

The trial was comprised of patients with varying forms of epilepsy, with the majority having TSC, a genetic disorder characterized by the growth of noncancerous (benign tumors) in many parts of …

Continue Reading

Posted in Client News| Tagged |

Medical Marijuana, Inc. Portfolio of Companies Announces Expansion of Offices and Warehouse Operations in California

SAN DIEGO, Oct. 11, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that it has expanded the size of its operations warehouse, more than tripling the size of the previous site.

This expansion is a direct result of the rapid sales growth within the portfolio of companies, and with this growth over the coming months will come approximately 20 new employment opportunities at the operations facility.

“This expansion has been needed for a while now, as we were bursting at the seams. The most exciting thing about our new larger facilities and staff is we will be able to process as many as five times the number of orders than previously possible,” said Medical Marijuana, Inc. Subsidiary Kannaway® CEO Blake Schroeder.

This will allow the Medical Marijuana, Inc. portfolio of companies, such as wholly owned subsidiaries Kannaway® and HempMeds®, …

Continue Reading

Posted in Client News| Tagged |

Medical Marijuana, Inc. Targets New $11 Billion Market Opportunity as World Anti-Doping Agency Removes CBD From Banned Substances List

SAN DIEGO, Oct. 10, 2017 /PRNewswire/ —Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that it will move forward with market expansion efforts in athletics with recent announcement by the World Anti-Doping Agency (WADA), the foundation initiated by the International Olympic Committee to coordinate and monitor drug use in sports, that cannabidiol (CBD) will be removed from its list of banned substances in 2018.

Medical Marijuana, Inc.’s Real Scientific Hemp Oil-X™ (RSHO-X)™ CBD hemp oil, which is the only product on the market to be recognized by international governments to be completely free of tetrahydrocannabinol (THC), the well-known psychoactive compound in marijuana, is an ideal option for athletes looking to safely incorporate cannabinoids into their regimen. Derived from industrial hemp and imported from Europe through the world’s first CBD pipeline, RSHO-X was the first cannabis product approved by the Mexican Federal government …

Continue Reading

Posted in Client News| Tagged , |